Am J Transplant, Volume 19, Suppl 3 Archives - Page 117 of 214 - ATC Abstracts

2019 American Transplant Congress
Multicenter Experience Evaluating Outcomes of HCV-Seropositive Donors to HCV-Seronegative Recipients Liver Transplantation
K. Wijarnpreecha¹, B. Aqel², S. Pungpapong¹, C. Taner³, K. Reddy⁴, M. Leise⁵, R. Dickson²
¹Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, ²Gastroenterology and Hepatology, Mayo Clinic, Scottsdale, AZ, ³Transplant, Mayo Clinic, Jacksonville, FL, ⁴Transplant and Hepatobiliary Surgery, Mayo Clinic, Scottsdale, AZ, ⁵Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN
*Purpose: Grafts from hepatitis C virus (HCV)-seropositive donors can now be considered for liver transplant (LT) due to the advent of direct-acting antiviral agents (DAA).…
2019 American Transplant Congress
CXCL12-CXCR4-Mediated Chemotaxis is a Potential Mechanism for Monocyte Recruitment in Ischemia-Reperfusion Injury in Orthotopic Liver Transplant Patients
A. Q. Terry¹, R. A. Sosa¹, B. V. Naini¹, V. Groysberg¹, F. M. Kaldas², R. W. Busuttil², D. Gjertson¹, J. Kupiec-Weglinski², E. F. Reed¹
¹Pathology and Laboratory Medicine, University of California, Los Angeles, Los Angeles, CA, ²Surgery, University of California, Los Angeles, Los Angeles, CA
*Purpose: Ischemia-reperfusion injury (IRI) elicits cellular damage which lowers allograft survival in orthotopic liver transplant (OLT) patients. Damage-associated molecular patterns, such as high-mobility group box…
2019 American Transplant Congress
Excellent Outcome in African-American (AA), Type 1 and Type 2 Diabetic Recipients after Simultaneous Pancreas and Kidney Transplantation (SPK)
A. Gruessner, S. Saggi, R. W. Gruessner
SUNY Downstate Medical Center, Brooklyn, NY
*Purpose: African-American recipients (AA) are considered a high risk group for organ transplantation. As outcomes after pancreas transplantation have significantly improved, the number of transplants…
2019 American Transplant Congress
Risk Predictive Strategy to Expand Pancreas Donor Selection
J. W. Mensink¹, K. M. Ooms - de Vries², V. A. Huurman¹, R. A. Pol³, I. P. Alwayn¹, A. E. Braat¹
¹Department of Surgery; Division of Transplantation, Leiden University Medical Center, Leiden, Netherlands, ²Dutch Transplant Foundation, Leiden, Netherlands, ³Department of Surgery; Division of Transplantation, University Medical Center Groningen, Groningen, Netherlands
*Purpose: The discrepancy between the number of patients on the waiting list and the number of donor pancreata for transplantation needs extension of accepting criteria…
2019 American Transplant Congress
Outcomes of Portal Vein Extension Grafts in Pancreas Transplantation: A Single-Centre Analysis
S. R. Punjala, B. L. Phillips, N. Karydis, F. Calder, C. J. Callaghan
Department of Nephrology, Renal Transplantation and Urology, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom
*Purpose: Surgical dogma suggests that portal vein extension grafts (PVEGs) in pancreas transplantation should be strenuously avoided, though the evidence-base is lacking. In our unit,…
2019 American Transplant Congress
Impact of an mHealth, Electronic Pillbox Intervention on Tacrolimus Variability in Kidney Transplantation: Results of a Prospective Randomized Clinical Trial
J. W. McGillicuddy, L. Sox, J. Chandler, F. Treiber, D. Taber
Medical University of South Carolina, Charleston, SC
*Purpose: Medication non-adherence (MNA) is a major risk factor and leading cause of late allograft loss in kidney transplant (KTX) recipients. Tacrolimus trough concentration variability,…
2019 American Transplant Congress
Characteristics And Outcomes Of Early Onset Cancers After Kidney Transplantation
W. Lim¹, E. Au², A. Krishnan¹, G. Wong²
¹Sir Charles Gairdner Hospital, Perth, Australia, ²University of Sydney & Westmead Hospital, Sydney, Australia
*Purpose: Incident cancers developing after kidney transplantation are associated with significant morbidity and mortality and therefore age-appropriate cancer screening is recommended to identify asymptomatic cancers…
2019 American Transplant Congress
Post-transplant Lymphoproliferative Disorder Following Intestine Transplantation: Contemporary Single Center Experience
A. Zimmerman, J. Hawksworth, A. Kroemer, P. Radkani, K. Khan, S. Kaufman, N. Yazigi, S. Subramanian, T. Fishbein, C. Matsumoto
Georgetown Transplant Institute, MedStar Georgetown University Hospital, Washington, DC
*Purpose: The purpose of this study was to examine the characteristics and risk factors for PTLD after intestinal transplant.*Methods: Retrospective review of intestinal transplant recipients…
2019 American Transplant Congress
The Rapidly Aging Population of Liver Transplant Patients with Hepatocellular Carcinoma
J. B. Rubin, G. Cullaro, N. Mehta, J. C. Lai
Division of Gastroenterology & Hepatology, UCSF, San Francisco, CA
*Purpose: Hepatocellular carcinoma (HCC) is the fastest rising cause of cancer-related mortality in the US and a leading indication for liver transplant (LT). Direct acting…
2019 American Transplant Congress
Organ Procurement Organization Performance is Not Related to Educational Spending
J. P. Roberts¹, J. Bragg-Gresham², P. Held³
¹Univ of California-San Francisco, San Francisco, CA, ²Nephrology, University of Michigan, Ann Arbor, MI, ³Stanford University, Stanford, CA
*Purpose: We examined the educational spending by OPOs in relationship to OPO performance metrics.*Methods: Data sources: OPO Cost Reports (CMS 216-94 Form), SRTR OPO Specific…